Editorial

You have full text access to this OnlineOpen article

Perioperative chemotherapy for urothelial cancer†

How have we made a “sow's ear” out of a chemotherapy-sensitive tumor?

  1. Tanya B. Dorff MD,
  2. David I. Quinn MBBS, PhD‡,*

Article first published online: 30 JUL 2009

DOI: 10.1002/cncr.24569

Issue

Cancer

Cancer

Volume 115, Issue 22, pages 5139–5142, 15 November 2009

Additional Information

How to Cite

Dorff, T. B. and Quinn, D. I. (2009), Perioperative chemotherapy for urothelial cancer. Cancer, 115: 5139–5142. doi: 10.1002/cncr.24569

Author Information

  1. Division of Oncology, University of Southern California, Los Angeles, California

  1. ‡

    Fax: (323) 865-0061

*Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Suite 3453, Los Angeles, CA 90033

  1. †

    See referenced Original Article on pages 5193–201, this issue.

Publication History

  1. Issue published online: 3 NOV 2009
  2. Article first published online: 30 JUL 2009
  3. Manuscript Accepted: 6 FEB 2009
  4. Manuscript Received: 3 FEB 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (81K)

Urothelial cancer is very responsive to chemotherapy. The deficit in translating this into improved patient outcome is a major blight on contemporary practice in urologic oncology.

View Full Article (HTML) Get PDF (81K)